The Prevalence of Dysglycemia-Based Chronic Disease in a
European Population - a New Paradigm to Address Diabetes
Burden: A Kardiovize Study

J 2021

The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study

GONZALEZ-RIVAS, J. P., J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA et. al.

Základní údaje

Originální název

The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study

Autoři

GONZALEZ-RIVAS, J. P. (garant), J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA (804 Ukrajina, domácí), Ota HLINOMAZ (203 Česká republika), Petr ŽÁK (203 Česká republika), Sarka KUNZOVA (203 Česká republika), R. NIETO-MARTINEZ, Maria SKLADANA, Jan BROZ (203 Česká republika), J. P. HERNANDEZ, F. LOPEZ-JIMENEZ a G. B. STOKIN

Vydání

Endocrine Practice, Jacksonville, American Association of Clinical Endocrinology, 2021, 1530-891X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30202 Endocrinology and metabolism

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 3.701

Kód RIV

RIV/00216224:14110/21:00121637

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1016/j.eprac.2020.10.003

UT WoS

000644659800012

Klíčová slova anglicky

cardiovascular disease; diabetes; epidemiology; type 2 diabetes mellitus

Štítky

14110525, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 14. 3. 2022 13:19, Mgr. Tereza Miškechová

Anotace

V originále

Objective: To determine the prevalence rate and associated risk factors for each stage of the Dysglycemia-Based Chronic Disease (DBCD) model, which 4 distinct stages and prompts early prevention to avert Diabetes and cardiometabolic complications. Methods: Subjects between 25 and 64 years old from a random population-based sample were evaluated in Czechia from 2013 to 2014 using a cross-sectional design. DBCD stages were: stage 1 "insulin resistance" (inferred risk from abdominal obesity or a family history of diabetes); stage 2 "prediabetes"(fasting glucose between 5.6 and 6.9 mmol/L); stage 3 "type 2 diabetes (T2D)" (self-report of T2D or fasting glucose >= 7 mmol/L); and stage 4 "vascular complications" (T2D with cardiovascular disease). Results: A total of 2147 subjects were included (57.8% women) with a median age of 48 years. The prevalence of each DBCD stage were as follows: 54.2% (stage 1); 10.3% (stage 2), 3.7% (stage 3); and 1.2% (stage 4). Stages 2 to 4 were more frequent in men and stage 1 in women (P < .001). Using binary logistic regression analysis adjusting by age/sex, all DBCD stages were strongly associated with abnormal adiposity, hypertension, dyslipidemia, and smoking status. Subjects with lower educational levels and lower income were more likely to present DBCD. Conclusion: Using the new DBCD framework and available metrics, 69.4% of the population had DBCD, identifying far more people at risk than a simple prevalence rate for T2D (9.2% in Czechia, 2013-2014). All stages were associated with traditional cardiometabolic risk factors, implicating common pathophysiologic mechanisms and a potential for early preventive care. The social determinants of health were related with all DBCD stages in alarming proportions and will need to be further studied. (C) 2020 AACE. Published by Elsevier Inc.

Citovat

GONZALEZ-RIVAS, J. P., J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA, Ota HLINOMAZ, Petr ŽÁK, Sarka KUNZOVA, R. NIETO-MARTINEZ, Maria SKLADANA, Jan BROZ, J. P. HERNANDEZ, F. LOPEZ-JIMENEZ a G. B. STOKIN. The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study. Endocrine Practice. Jacksonville: American Association of Clinical Endocrinology, 2021, roč. 27, č. 5, s. 455-462. ISSN 1530-891X. Dostupné z: https://dx.doi.org/10.1016/j.eprac.2020.10.003.

@article{1770957,
   author = {GonzalezandRivas, J. P. and Mechanick, J. I. and InfanteandGarcia, M. M. and MedinaandInojosa, J. R. and Pavlovska, Iuliia and Hlinomaz, Ota and Žák, Petr and Kunzova, Sarka and NietoandMartinez, R. and Skladana, Maria and Broz, Jan and Hernandez, J. P. and LopezandJimenez, F. and Stokin, G. B.},
   article_location = {Jacksonville},
   article_number = {5},
   doi = {http://dx.doi.org/10.1016/j.eprac.2020.10.003},
   keywords = {cardiovascular disease; diabetes; epidemiology; type 2 diabetes mellitus},
   language = {eng},
   issn = {1530-891X},
   journal = {Endocrine Practice},
   title = {The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study},
   url = {https://www.sciencedirect.com/science/article/pii/S1530891X20483600?via%3Dihub},
   volume = {27},
   year = {2021}
}

TY  - JOUR
ID  - 1770957
AU  - Gonzalez-Rivas, J. P. - Mechanick, J. I. - Infante-Garcia, M. M. - Medina-Inojosa, J. R. - Pavlovska, Iuliia - Hlinomaz, Ota - Žák, Petr - Kunzova, Sarka - Nieto-Martinez, R. - Skladana, Maria - Broz, Jan - Hernandez, J. P. - Lopez-Jimenez, F. - Stokin, G. B.
PY  - 2021
TI  - The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study
JF  - Endocrine Practice
VL  - 27
IS  - 5
SP  - 455-462
EP  - 455-462
PB  - American Association of Clinical Endocrinology
SN  - 1530891X
KW  - cardiovascular disease
KW  - diabetes
KW  - epidemiology
KW  - type 2 diabetes mellitus
UR  - https://www.sciencedirect.com/science/article/pii/S1530891X20483600?via%3Dihub
N2  - Objective: To determine the prevalence rate and associated risk factors for each stage of the Dysglycemia-Based Chronic Disease (DBCD) model, which 4 distinct stages and prompts early prevention to avert Diabetes and cardiometabolic complications. Methods: Subjects between 25 and 64 years old from a random population-based sample were evaluated in Czechia from 2013 to 2014 using a cross-sectional design. DBCD stages were: stage 1 "insulin resistance" (inferred risk from abdominal obesity or a family history of diabetes); stage 2 "prediabetes"(fasting glucose between 5.6 and 6.9 mmol/L); stage 3 "type 2 diabetes (T2D)" (self-report of T2D or fasting glucose >= 7 mmol/L); and stage 4 "vascular complications" (T2D with cardiovascular disease). Results: A total of 2147 subjects were included (57.8% women) with a median age of 48 years. The prevalence of each DBCD stage were as follows: 54.2% (stage 1); 10.3% (stage 2), 3.7% (stage 3); and 1.2% (stage 4). Stages 2 to 4 were more frequent in men and stage 1 in women (P < .001). Using binary logistic regression analysis adjusting by age/sex, all DBCD stages were strongly associated with abnormal adiposity, hypertension, dyslipidemia, and smoking status. Subjects with lower educational levels and lower income were more likely to present DBCD. Conclusion: Using the new DBCD framework and available metrics, 69.4% of the population had DBCD, identifying far more people at risk than a simple prevalence rate for T2D (9.2% in Czechia, 2013-2014). All stages were associated with traditional cardiometabolic risk factors, implicating common pathophysiologic mechanisms and a potential for early preventive care. The social determinants of health were related with all DBCD stages in alarming proportions and will need to be further studied. (C) 2020 AACE. Published by Elsevier Inc.
ER  -

GONZALEZ-RIVAS, J. P., J. I. MECHANICK, M. M. INFANTE-GARCIA, J. R. MEDINA-INOJOSA, Iuliia PAVLOVSKA, Ota HLINOMAZ, Petr ŽÁK, Sarka KUNZOVA, R. NIETO-MARTINEZ, Maria SKLADANA, Jan BROZ, J. P. HERNANDEZ, F. LOPEZ-JIMENEZ a G. B. STOKIN. The Prevalence of Dysglycemia-Based Chronic Disease in a European Population - a New Paradigm to Address Diabetes Burden: A Kardiovize Study. \textit{Endocrine Practice}. Jacksonville: American Association of Clinical Endocrinology, 2021, roč.~27, č.~5, s.~455-462. ISSN~1530-891X. Dostupné z: https://dx.doi.org/10.1016/j.eprac.2020.10.003.

Podrobný výpis o publikaci